Back
Back
Symptom Driven ICS/LABA - Adolescent Study
Official Title
Symptom-driven ICS/LABA therapy for adolescents with asthma non-adherent to daily maintenance inhalers
Study Details
The purpose of this study is to better understand what adolescent asthma patients' views on taking inhalers are, and assess if patients would have better asthma control and be more adherent to a different inhaler regimen than what is currently prescribed.
Principal Investigator
Dr. James Krings
IRB Number
202203033
Eligibility
1. Participants must be 12 to 17 years
2. Participants must have asthma and must be prescribed a maintenance inhaler
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu